OneLAX Docusate Sodium Liquid — Class II drug recall D-0025-2025
Ongoing recall by Akron Pharma, Inc., reported 2024-10-30, distributed nationwide. CGMP Deviations
| Recall number | D-0025-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Akron Pharma, Inc., Fairfield, NJ, United States |
| Recall initiated | 2024-10-15 |
| Classified | 2024-10-24 |
| Reported by FDA | 2024-10-30 |
| Distributed | Nationwide (US) |
| Quantity | 10,845 bottles |
| Reason classes | cgmp |
| NDC | 71399-0039-06 |
| Lot numbers | ODS230001A, ODS230002A, ODS230003A |
| Expiration dates | 2025-10, 2025-11 |
Product
OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473 mL) bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., Fairfield, NJ 07004, NDC 71399-0039-06.
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0025-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.